Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

SpringWorks Therapeutics Q2 2024 GAAP EPS $(0.54) Beats $(1.13) Estimate, Sales $59.733M Beat $34.343M Estimate

Author: Benzinga Newsdesk | August 07, 2024 06:38am
SpringWorks Therapeutics (NASDAQ:SWTX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(1.13) by 52.21 percent. This is a 56.8 percent increase over losses of $(1.25) per share from the same period last year. The company reported quarterly sales of $59.733 million which beat the analyst consensus estimate of $34.343 million by 73.93 percent.

Posted In: SWTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist